Not Yet Recruiting
Trial of Selumetinib and Bromodomain Inhibitor With Durvalumab for Sarcomas
NCT05253131
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Fibrosarcoma, Genetic Diseases, Inborn, +23 more
- Locations
-
- The University of Alabama at Birmingham Birmingham, Alabama, United States